|
Hot Stocks
| ShowHide Related Items >><< - $643.63 /
+13.22 (+2.10%) - 03/16/23
- Broadcom director sells $1.98M in common stock
- 03/15/23
- Broadcom shipping Tomahawk 5 family of Ethernet chips in production volume
- 03/06/23
- Broadcom announces availability of 5nm 100G/lane optical PAM-4 DSP PHY
- 03/02/23
- VMware sees deal to be acquired by Broadcom completed in Broadcom's FY23
- $643.63 /
+13.22 (+2.10%) - 03/03/23 OTR Global
- Qualcomm displacing Broadcom for S23 components, says OTR Global
- 03/03/23 Truist
- Broadcom price target raised to $700 from $659 at Truist
- 03/03/23 Susquehanna
- Broadcom price target raised to $690 from $685 at Susquehanna
- 03/03/23 TD Cowen
- Broadcom price target raised to $615 from $540 at TD Cowen
- $643.63 /
+13.22 (+2.10%) - 03/02/23
- Broadcom sees Q2 revenue approximately $8.7B, consensus $8.59B
- 03/02/23
- Broadcom reports Q1 adjusted EPS $10.33, consensus $10.10
- 03/02/23
- VMware reports Q4 EPS $2.13, consensus $1.92
- 03/02/23
- Notable companies reporting after market close
- $643.63 /
+13.22 (+2.10%) - 03/04/23
- Boom time for farmers can last, Deere stands to benefit, Barron's says
- 02/27/23
- Broadcom set to receive EU warning over VMware deal, Reuters reports
- 02/13/23
- Democrats want tighter limit on stock buybacks in chip subsidies, Bloomberg says
- 02/03/23
- Broadcom CEO Tan plans to seek more acquisitions after VMware, FT reports
- $643.63 /
+13.22 (+2.10%) - 03/03/23
- What You Missed On Wall Street On Friday
- 03/03/23
- What You Missed On Wall Street This Morning
- 03/02/23
- Fly Intel: After-Hours Movers
- 02/13/23
- What You Missed On Wall Street On Monday
- $643.63 /
+13.22 (+2.10%) - 03/03/23
- Early notable gainers among liquid option names on March 3rd
- 03/02/23
- Broadcom options imply 2.8% move in share price post-earnings
- 01/10/23
- Unusually active option classes on open January 10th
- 12/12/22
- Broadcom call volume above normal and directionally bullish
|
|
Hot Stocks
| ShowHide Related Items >><< - 16:59 Today
- First Majestic to reduce costs, suspend mining activities at Jerritt Canyon
- 11/28/22
- Metalla to acquire royalty portfolio from First Majestic for $20M
- 02/27/23 TD Securities
- First Majestic price target lowered to C$11 from C$12 at TD Securities
- 02/14/23 National Bank
- First Majestic price target lowered to C$11 from C$14.50 at National Bank
- 01/20/23 BMO Capital
- First Majestic price target lowered to C$9 from C$10.50 at BMO Capital
- 01/13/23 National Bank
- First Majestic price target raised to C$14.50 from C$13 at National Bank
- 03/13/23
- First Majestic Silver call volume above normal and directionally bullish
- 01/03/23
- Unusually active option classes on open January 3rd
|
|
Hot Stocks
| ShowHide Related Items >><< ORTX Orchard Therapeutics - 03/06/23
- Orchard Therapeutics expects cash to fund operations into 2025
- 02/27/23
- Orchard Therapeutics announces agreement for reimbursed access to Libmeldy
- 02/24/23
- Orchard Therapeutics announces presentation of results on OTL-200
- 02/10/23
- Orchard Therapeutics announces proposed ADS ratio change
ORTX Orchard Therapeutics - 03/15/23 Stifel
- Orchard Therapeutics target adjusted to $22 at Stifel after ADS ratio change
- 03/13/23 Oppenheimer
- Orchard Therapeutics price target raised to $37 from $5 at Oppenheimer
- 07/18/22 Oppenheimer
- Orchard Therapeutics assumed with an Outperform at Oppenheimer
- 05/13/22 Barclays
- Orchard Therapeutics price target lowered to $4 from $6 at Barclays
ORTX Orchard Therapeutics - 03/06/23
- Orchard Therapeutics reports Q4 EPS (6c), consensus (21c)
- 01/09/23
- Orchard Therapeutics sees Q4 Libmeldy sales $5.8M
- 11/14/22
- Orchard Therapeutics reports Q3 EPS (37c), consensus (24c)
ORTX Orchard Therapeutics - 01/09/23
- Biotech Alert: Searches spiking for these stocks today
|
|
Hot Stocks
| ShowHide Related Items >><< - 03/15/23
- North American rail traffic down 6.1% for the week ending March 11
- 03/08/23
- North American rail traffic down 4.4% for the week ending March 4
- 03/01/23
- Canadian National announces record month for Western Canadian grain movement
- 03/01/23
- North American rail traffic down 3.4% for the week ending February 25
- 01/25/23 Desjardins
- Canadian National price target lowered to C$179 from C$180 at Desjardins
- 01/25/23 CIBC
- Canadian National price target lowered to C$175 from C$181 at CIBC
- 01/25/23 BMO Capital
- Canadian National price target lowered to C$180 from C$185 at BMO Capital
- 01/25/23 Scotiabank
- Canadian National price target lowered to C$167 from C$170 at Scotiabank
- 01/24/23
- Canadian National reports Q4 EPS C$2.10, consensus C$2.08
- 10/25/22
- Canadian National raises FY22 adjusted EPS view to up 25% from up 15%-20%
- 10/25/22
- Canadian National reports Q3 adjusted EPS C$2.13 vs. C$2.37 last year
- 03/07/23
- Ohio crash highlights gap in federal safety regulations, NY Times reports
- 03/03/23
- Norfolk Southern, railroads to join close-call reporting system, WSJ reports
- 12/01/22
- Senate approves bill to force tentative rail labor agreement, CNBC says
- 11/30/22
- House passes bill to avoid rail strike, NBC News reports
- 01/24/23
- Fly Intel: After-Hours Movers
- 11/30/22
- What You Missed On Wall Street On Wednesday
- 11/29/22
- What You Missed On Wall Street On Tuesday
- 11/29/22
- What You Missed On Wall Street This Morning
|
|
Periodicals
| ShowHide Related Items >><< - 03/15/23
- Thermo Fisher CEO sells $8.24M in common stock
- 02/22/23
- Thermo Fisher raises quarterly dividend 17% to 35c per share
- 02/14/23
- Lone Pine exited PayPal, initiated AMD position during Q4
- 02/07/23
- Elektrofi announces collaboration with Thermo Fisher
- 03/07/23
- KKR sells four Class A self-storage properties for $80M
- 02/01/23
- KKR announces significant investment in Groundworks
- 01/19/23
- KKR says KREST received repurchase requests for 8.1% of fund's NAV in Q1
- 01/17/23
- S&P Global to sell Engineering Solutions business to KKR for $975M
- 02/09/23
- Repligen appoints Martin Madaus to board of directors
- 02/07/23
- Carlyle approves increase in common stock dividend to $1.40 annual rate
- 02/06/23
- Carlyle Group names Harvey Schwartz as CEO, board member
- 02/02/23
- Carlyle in talks with ex-Goldman exec Schwartz for CEO role, Semafor says
- 03/09/23
- Baxter treatment of short bowel syndrome granted FDA orphan designation
- 02/09/23
- Baxter falls -13.6%
- 02/09/23
- Baxter falls -10.1%
- 02/01/23
- Miromatrix Medical, Baxter enter research agreement for ALF
- 03/10/23 Chardan
- Gensight Biologics price target lowered to EUR 13 from EUR 15 at Chardan
- 02/06/23 Jefferies
- Jefferies says Catalent could be valued near $93 on average CDMO buyout multiple
- 02/02/23 Morgan Stanley
- Thermo Fisher price target raised to $670 from $613 at Morgan Stanley
- 02/02/23 TD Cowen
- Thermo Fisher price target raised to $711 from $690 at Cowen
- 02/13/23 Barclays
- Baxter price target lowered to $54 from $63 at Barclays
- 02/10/23 TD Cowen
- Baxter price target lowered to $45 from $70 at Cowen
- 02/06/23 KeyBanc
- Baxter price target lowered to $60 from $73 at KeyBanc
- 02/01/23 Piper Sandler
- Miromatrix MiroliverELAP timeline pushed out two or three quarters, says Piper
- 03/02/23 Barclays
- KKR initiated with an Overweight at Barclays
- 02/08/23 Deutsche Bank
- KKR price target raised to $70 from $67 at Deutsche Bank
- 02/08/23 Wells Fargo
- KKR price target raised to $65 from $59 at Wells Fargo
- 02/08/23 JMP Securities
- KKR price target raised to $80 from $72 at JMP Securities
- 03/02/23 Barclays
- Carlyle Group initiated with an Overweight at Barclays
- 02/08/23 Deutsche Bank
- Carlyle Group price target raised to $43 from $41 at Deutsche Bank
- 02/08/23 Piper Sandler
- Carlyle Group price target lowered to $48 from $58 at Piper Sandler
- 01/31/23 BMO Capital
- Franklin Resources price target raised to $23 from $22 at BMO Capital
- 02/01/23
- Thermo Fisher sees Q1 EPS over 20% of full-year total, consensus $5.41
- 02/01/23
- Thermo Fisher sees FY23 adjusted EPS $23.70, consensus $23.21
- 02/01/23
- Thermo Fisher reports Q4 adjusted EPS $5.40, consensus $5.19
- 01/31/23
- Notable companies reporting before tomorrow's open
- 02/07/23
- KKR reports Q4 distributable EPS 92c, consensus 86c
- 02/06/23
- Notable companies reporting before tomorrow's open
- 11/01/22
- KKR reports Q3 distributable EPS 93c, consensus 85c
- 02/07/23
- Carlyle Group reports Q4 distributable EPS $1.01, consensus 96c
- 11/08/22
- Carlyle Group reports Q3 distributable EPS $1.42, consensus $1.06
- 02/09/23
- Baxter sees FY23 adjusted EPS $2.75-$2,95, consensus $3.56
- 02/09/23
- Baxter sees Q1 adjusted EPS 46c-50c, consensus 76c
- 02/09/23
- Baxter reports Q4 adjusted EPS 88c, consensus 94c
- 02/08/23
- Notable companies reporting before tomorrow's open
- 10/30/22
- Thermo Fisher said to near $2.3B deal for Binding Site, Bloomberg reports
- 03/14/23
- Buyout titans weighing purchases from SVB loan book, FT reports
- 01/19/23
- Epic, Match antitrust case against Google goes to trial in November, TC says
- 11/25/22
- KKR in advanced talks to acquire April. Bloomberg reports
- 11/25/22
- KKR near EUR 2.3B deal for CVC's insurance broker April, Bloomberg says
- 02/06/23
- Carlyle expected to name ex-Goldman exec as CEO this week, Bloomberg reports
- 01/13/23
- Mason, Pruzan have held talks with Carlyle for CEO role, FT reports
- 12/22/22
- Carlyle Group struggles to find permanent CEO, FT reports
- 02/01/23
- What You Missed On Wall Street On Wednesday
- 02/01/23
- What You Missed On Wall Street This Morning
- 02/01/23
- Fly Intel: Pre-market Movers
- 12/07/22
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 01/13/23
- Sell these stocks now, proven algorithm says
- 12/20/22
- What You Missed This Week in Video Games
- 11/22/22
- What You Missed This Week in Video Games
- 11/09/22
- What You Missed On Wall Street On Wednesday
- 12/22/22
- What You Missed On Wall Street On Thursday
- 12/22/22
- What You Missed On Wall Street This Morning
- 11/15/22
- What You Missed On Wall Street On Tuesday
- 11/08/22
- Fly Intel: Pre-market Movers
- 02/09/23
- Fly Intel: Pre-market Movers
- 01/06/23
- What You Missed On Wall Street On Friday
- 01/06/23
- What You Missed On Wall Street This Morning
- 10/27/22
- Fly Intel: Pre-market Movers
- 02/01/23
- Early notable gainers among liquid option names on February 1st
- 01/10/23
- Early notable gainers among liquid option names on January 10th
- 03/07/23
- Unusually active option classes on open March 7th
- 02/21/23
- Baxter call volume above normal and directionally bullish
- 02/09/23
- Baxter put volume heavy and directionally bearish
- 01/24/23
- Baxter put volume heavy and directionally bearish
- 01/05/23
- Baxter call volume above normal and directionally bullish
|
|
On The Fly
|
Check out this evening's… ShowHide Related Items >><< - 03/12/23
- Ventyx Biosciences provides update on Silicon Valley Bank financial exposure
- 02/14/23
- Third Point buys AIG, exits T-Mobile in Q4
- 01/26/23
- Ventyx Biosciences announces pipeline updates, strategic priorities
- 01/12/23
- Ventyx Biosciences appoints Allison Hulme, Ph.D. to board
- 16:12 Today
- Wag! Group directors buy $2.66M in common stock
- 02/14/23
- Wag! Group director buys $2.62M in common stock
- 01/03/23
- Wag! Group to acquire Dog Food Advisor assets Clicks and Traffic LLC for $9M
- 16:02 Today
- Nano Dimension shareholders support Murchinson proposals
- 10:08 Today
- Nano Dimension responds to 'misconceptions' by Anson
- 03/13/23
- Nano Dimension announces Israeli court decision to keep Murchinson hearing date
- 03/13/23
- Nano Dimension CEO provides rationale for acquisition of Stratasys
- 03/13/23
- Lantern Pharma says no exposure to SVB, Signature Bank or Silvergate Capital
- 03/09/23
- Lantern announces new data and development focus for LP-100 with PARPi
- 03/06/23
- Lantern forms Starlight Therapeutics to advance therapies for CNS/brain cancers
- 02/21/23
- Lantern Pharma trading resumes
- 16:15 Today
- Harmonic jumps 8% to $14.20 after technology partnership with Charter
- 16:09 Today
- Harmonic, Charter announce partnership
- 02/16/23
- Harmonic CFO Sanjay Kalra to resign, Jeremy Rosenberg named interim CFO
FUSN Fusion Pharmaceuticals - 16:08 Today
- Fusion Pharmaceuticals: First patient dosed in Phase 1 Study of FPI-2059
- 02/13/23
- Fusion Pharmaceuticals jumps 39% after buying prostate cancer detection assets
- 02/13/23
- Fusion Pharmaceuticals trading resumes
- 02/13/23
- Fusion Pharmaceuticals to resume trading at 4:35 pm ET
- 10/31/22 EF Hutton
- Lantern Pharma initiated with a Buy at EF Hutton
- 02/08/23 Jefferies
- Jefferies reveals top broadband plays, sees 5 years of strong growth
- 01/31/23 Barclays
- Harmonic price target raised to $20 from $17 at Barclays
- 01/09/23 Jefferies
- Harmonic upgraded to Buy from Hold at Jefferies
- 01/09/23 Jefferies
- Harmonic upgraded to Buy from Hold at Jefferies
- 11/21/22 Oppenheimer
- Wag! Group initiated with an Outperform at Oppenheimer
- 11/14/22 DA Davidson
- Wag! Group price target lowered to $6.50 from $11 at DA Davidson
- 10/17/22 Roth MKM
- Wag! Group initiated with a Buy at Roth Capital
- 10/14/22 Craig-Hallum
- Wag! Group initiated with a Buy at Craig-Hallum
- 03/10/23 Lake Street
- Nano Dimension made 'lowball offer' Stratasys won't accept, says Lake Street
FUSN Fusion Pharmaceuticals - 12/01/22 B. Riley
- Fusion Pharmaceuticals resumed with a Buy at B. Riley
- 11/30/22 SVB Securities
- Fusion Pharmaceuticals initiated with an Outperform at SVB Securities
- 09/15/22 Truist
- Truist starts Fusion Pharmaceuticals at Buy with $10 price target
- 09/15/22 Truist
- Fusion Pharmaceuticals initiated with a Buy at Truist
- 16:28 Today Wells Fargo
- Wells starts Ventyx at Overweight, sees multiple catalysts in next 12-18 months
- 16:05 Today Wells Fargo
- Ventyx Biosciences initiated with an Overweight at Wells Fargo
- 06:24 Today Oppenheimer
- Ventyx Biosciences price target raised to $65 from $60 at Oppenheimer
- 01/31/23 Canaccord
- Ventyx Biosciences price target raised to $54 from $35 at Canaccord
- 11/03/22
- Ventyx Biosciences reports Q3 EPS (59c), consensus (44c)
- 02/21/23
- Wag! Group sees FY23 revenue $75M-$77M, consensus $69.6M
- 02/21/23
- Wag! Group reports Q4 EPS 7c, consensus (10c)
- 11/10/22
- Wag! Group sees FY22 revenue $51M-$52M, consensus $48.65M
- 11/10/22
- Wag! Group reports Q3 EPS ($1.67), may note compare to consensus (34c)
- 01/24/23
- Nano Dimension reports Q4 revenue $12.1M, up 61% vs. 4Q21
- 12/01/22
- Nano Dimension reports Q3 EPS (26c) vs. (7c) last year
- 10/24/22
- Nano Dimension sees Q3 revenue $10M
- 16:02 Today
- Lantern Pharma reports Q4 EPS (31c), two estimates (47c)
- 02/27/23
- Lantern Pharma in R&D collaboration with TTC Oncology for drug candidate TTC-352
- 01/30/23
- Harmonic sees FY23 non-GAAP EPS 56c-72c, consensus 74c
- 01/30/23
- Harmonic sees Q1 non-GAAP EPS 7c-10c, consensus 10c
- 01/30/23
- Harmonic reports Q4 non-GAAP EPS 17c, consensus 14c
- 10/31/22
- Harmonic reports Q3 non-GAAP EPS 13c, consensus 10c
FUSN Fusion Pharmaceuticals - 03/16/23
- Fusion Pharmaceuticals reports Q4 EPS (55c), consensus (56c)
- 11/08/22
- Fusion Pharmaceuticals reports Q3 EPS (55c), consensus (50c)
- 03/07/23
- Nano Dimension receives purchase order for DragonFly IV system
- 12/19/22
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 11/17/22
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 02/21/23
- Fly Intel: After-Hours Movers
- 11/10/22
- Fly Intel: After-Hours Movers
- 10/14/22
- What You Missed On Wall Street On Friday
- 10/14/22
- What You Missed On Wall Street This Morning
- 03/14/23
- What You Missed On Wall Street On Tuesday
- 03/14/23
- What You Missed On Wall Street This Morning
- 03/10/23
- What You Missed On Wall Street On Friday
- 03/10/23
- What You Missed On Wall Street This Morning
- 01/30/23
- Fly Intel: After-Hours Movers
- 10/31/22
- Fly Intel: After-Hours Movers
- 03/07/23
- Unusually active option classes on open March 7th
- 01/20/23
- Largest borrow rate increases among liquid names
|
|
Hot Stocks
| ShowHide Related Items >><< - $183.22 /
+3.175 (+1.76%) - 03/14/23
- Cathie Wood's ARK Investment bought 2.6K shares of Tesla today
- 03/13/23
- Cathie Wood's ARK Investment bought 26.7K shares of Tesla today
- 03/06/23
- Tesla issues recall notice for 3,470 Model Y vehicles in U.S.
- 02/27/23
- Tesla temporarily halts FSD beta software installations until recall addressed
- $183.22 /
+3.175 (+1.76%) - 07:50 Today Morgan Stanley
- XPeng price target raised to $12.50 from $12 at Morgan Stanley
- 07:49 Today Morgan Stanley
- Li Auto price target raised to $30 from $23 at Morgan Stanley
- 03/13/23 Wolfe Research
- Tesla downgraded to Peer Perform from Outperform at Wolfe Research
- 03/09/23 Morgan Stanley
- Morgan Stanley questions if Tesla has 'outgrown the Cybertruck'
- $183.22 /
+3.175 (+1.76%) - 03/02/23
- Aehr Test Systems reiterates annual guidance, comments on Tesla statements
- 01/25/23
- Tesla reports Q4 EPS $1.19, consensus $1.13
- 01/25/23
- Notable companies reporting after market close
- 10/19/22
- Tesla reports Q3 EPS $1.05, consensus 99c
- $183.22 /
+3.175 (+1.76%) - 03/14/23
- Tesla's Autopilot name lacks 'common sense,' Buttigieg tells Bloomberg
- 03/10/23
- Tesla faces 'criminal' allegations over Berlin Gigafactory, Electrek reports
- 03/10/23
- Tesla works with Asian material suppliers over battery concerns, Reuters report
- 03/08/23
- GM's EV push off to a slow start in 2023, WSJ reports
- $183.22 /
+3.175 (+1.76%) - 10:44 Today
- What You Missed This Week in EVs and Clean Energy
- 03/18/23
- Opening Day: China's Intchains, ICZOOM make U.S. debut
- 03/14/23
- What You Missed On Wall Street On Tuesday
- 03/14/23
- What You Missed On Wall Street This Morning
- $183.22 /
+3.175 (+1.76%) - 08:55 Today
- Notable open interest changes for March 20th
- 03/14/23
- Notable open interest changes for March 14th
- 03/13/23
- Notable open interest changes for March 13th
- 03/10/23
- Notable open interest changes for March 10th
|
|
Hot Stocks
| ShowHide Related Items >><< - 03/17/23
- Charles Schwab reports $16.5B in core net new assets over past five trading days
- 03/16/23
- Charles Schwab director buys $233.5K in common stock
- 03/15/23
- Charles Schwab director buys $2.0M in common stock
- 03/14/23
- Charles Schwab CEO buys $2.97M in common stock, CFO buys $289.8K
- 03/15/23 Credit Suisse
- Charles Schwab upgraded to Outperform from Neutral at Credit Suisse
- 03/14/23 JPMorgan
- Schwab funding concerns 'significantly de-risked,' says JPMorgan
- 03/14/23 Piper Sandler
- Charles Schwab price target lowered to $95 from $100 at Piper Sandler
- 03/14/23 Deutsche Bank
- Charles Schwab price target lowered to $83 from $109 at Deutsche Bank
- 01/18/23
- Charles Schwab reports Q4 adjusted EPS $1.07, consensus $1.09
- 01/17/23
- Notable companies reporting before tomorrow's open
- 10/27/22
- Charles Schwab backs 11%-13% year-over-year revenue growth outlook
|
|
Periodicals
|
Goldman Sachs (GS) chief… ShowHide Related Items >><< - 03/19/23
- Fly Intel: Top five weekend stock stories
- 03/16/23
- First Republic confirms it will receive deposits totaling $30B from banks
- 03/16/23
- Fed, Treasury say banks' deposits in First Republic show system's 'resilience'
- 03/16/23
- Group of banks confirm plan to make deposits totaling $30B in First Republic
- 13:55 Today
- S&P revises UBS Group outlook to Negative, affirms ratings
- 03/19/23
- Credit Suisse says UBS confident staff employment will be continued
- 03/19/23
- UBS acquires Credit Suisse for CHF 0.76 per share or CHF 3B
- 03/09/23 BofA
- Goldman Sachs price target raised to $425 from $384 at BofA
- 03/02/23 Seaport Global
- Goldman remains a top pick at Seaport after investor day
- 03/01/23 Jefferies
- Jefferies keeps Buy on Goldman Sachs, says 'questions remain' after investor day
- 02/27/23 Morgan Stanley
- Morgan Stanley not expecting new return targets at Goldman investor day
- 08:46 Today Barclays
- European Banks sector view downgraded to Neutral at Barclays
- 05:58 Today Societe Generale
- UBS downgraded to Hold from Buy at Societe Generale
- 05:16 Today BofA
- UBS upgraded to Buy from Neutral at BofA
- 03/16/23 JPMorgan
- Credit Suisse gets short-term relief, but questions remain, says JPMorgan
- 01/17/23
- Goldman Sachs reports Q4 EPS $3.32, consensus $5.48
- 10/18/22
- Goldman Sachs reports Q3 EPS $8.25, consensus $7.69
- 10/17/22
- Notable companies reporting before tomorrow's open
- 02/09/23
- Credit Suisse reports Q4 net revenue CHF 3.06B vs. CHF 4.58B last year
- 10/27/22
- Credit Suisse reports Q3 net revenue CHF 3.8B vs. CHF 5.43B last year
- 12:03 Today
- Big-bank CEOs discussing capital infusion for First Republic, WSJ says
- 03/18/23
- Biggest banks looking like winners, Barron's says
- 03/16/23
- Goldman Sach's plan for SVB underestimated danger of bad news, WSJ reports
- 03/15/23
- Treasury reviewing U.S. bank exposure to Credit Suisse, Bloomberg says
- 03/19/23
- Bank of England welcomes CS deal, says U.K. banks are safe, Reuters reports
- 03/19/23
- First Republic Bank looms large for regulators after CS sale, WSJ says
- 03/19/23
- UBS agrees to buy Credit Suisse for over $2B, Bloomberg reports
- 03/19/23
- UBS near deal to acquire Credit Suisse for $1B, NY Times reports
- 03/16/23
- What You Missed On Wall Street This Morning
- 02/24/23
- What You Missed On Wall Street On Friday
- 02/17/23
- What You Missed On Wall Street On Friday
- 02/17/23
- What You Missed On Wall Street This Morning
- 16:32 Today
- What You Missed On Wall Street On Monday
- 12:05 Today
- What You Missed On Wall Street This Morning
- 09:55 Today
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 08:54 Today
- Fly Intel: Pre-market Movers
- 03/09/23
- World Low Volatility ETF put volume heavy and directionally bearish
- 01/17/23
- Unusually active option classes on open January 17th
- 12/05/22
- World Low Volatility ETF put volume heavy and directionally bearish
- 10/18/22
- Unusually active option classes on open October 18th
- 08:55 Today
- Notable open interest changes for March 20th
- 03/17/23
- Notable open interest changes for March 17th
- 03/17/23
- Largest borrow rate increases among liquid names
- 03/16/23
- Unusually active option classes on open March 16th
|
|
Hot Stocks
| ShowHide Related Items >><< SGMA Sigmatron International - 01/04/23
- Sigmatron announces promotion of John Sheehan to president, EMS Operations
SGMA Sigmatron International - 12/09/22
- Sigmatron International reports Q2 EPS 14c vs 69c last year
|
